Sleptay

Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous system diseases.

Health and bio

Sleptay has no funding amount on record yet; its latest known round is Series A (Sep 2026). Recent Funding first saw it on October 4, 2026.

Raise history

1. September 28, 2026
   Series A · amount undisclosed
   DDecheng Capital (lead), CChina Merchants Venture, HHuatai Zijin Investment, MMorningside, QQianju Capital, SShunwei Capital
   Source: 163.com

Investors

• CChina Merchants Venture
• DDecheng Capital
• HHuatai Zijin Investment
• MMorningside
• QQianju Capital
• SShunwei Capital

Related other companies

• CClean TeamSep 30, 2026
• SShijing TechnologySep 29, 2026
• CCombine KidsSep 29, 2026
• CClearDefense Pest ControlSep 28, 2026
• XXunjie GuangyuanSep 28, 2026
• XXige EstateSep 28, 2026
• XXunying MobilitySep 28, 2026
• PPrimerry$760K · Sep 28, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sleptay.